drug manufacturers

EU to unveil major pharmaceutical reform for cheaper drugs and faster access

The European Union is set to announce significant reforms to its pharmaceutical regulations today, aiming to reduce costs, prevent drug shortages, and expedite the introduction of new medicines. These changes represent the EU’s most extensive overhaul of pharmaceutical legislation in two decades, partly inspired by the benefits of more streamlined processes, joint action, and improved transparency observed during the Covid-19…